Recombinant Human TUSC2 Protein ，GST

TUSC2 (Tumor Suppressor Candidate 2) is a gene located on chromosome 3p21.3, a region frequently associated with deletions in various types of cancers, including lung and breast cancer. Research has indicated that TUSC2 functions as a tumor suppressor, playing a critical role in inhibiting cell proliferation and promoting apoptosis in malignant cells. The protein encoded by TUSC2 has been shown to have anti-cancer properties, making it a promising candidate for gene therapy applications. Scientists have been investigating the potential of recombinant TUSC2 protein for therapeutic use, particularly its ability to re-establish normal apoptotic pathways in tumor cells. Studies have revealed that TUSC2 might interact with several cellular pathways, influencing factors such as DNA repair, cell cycle regulation, and responses to cellular stress. Efforts to produce TUSC2 as a recombinant protein have focused on optimizing its expression in various systems, including bacterial and mammalian cells. The availability of recombinant TUSC2 opens avenues for in-depth studies into its mechanism of action, as well as its potential as a biomarker for cancer diagnosis and prognosis. Moreover, preclinical trials using TUSC2 gene delivery have shown promise in selectively targeting cancer cells, underscoring the importance of TUSC2 in cancer research and its potential role in developing future therapies. Overall, the study of TUSC2 and its recombinant protein continues to provide insights into cancer biology and therapeutic innovation, highlighting its significance as a potential tool in the fight against cancer.